logo
Should higher earners pay to use the NHS?

Should higher earners pay to use the NHS?

Times7 days ago
A report by the International Monetary Fund has called on the British government to consider charging those on high incomes to use the NHS. The report suggested that in the face of 'tough fiscal choices' facing the chancellor, 'access to public service could depend more on an individual's capacity to pay'. We ask two experts whether this idea could work.
The country can no longer afford to provide healthcare to everyone free at the point of use. It is time for middle and high-earners to start paying.
Nye Bevan's ambition was laudable. However, taxpayer-funded spending on healthcare has reached levels that were unimaginable in the 1940s. It is now the equivalent of the entire GDP of Portugal.
These taxes not only place a heavy burden on households and firms, they also act as a disincentive towards productive activities and dampen economic growth.
In Policy Exchange's report, The NHS — a Suitable Case for Treatment?, we showed that not only is the NHS incredibly expensive, it is also producing far worse outcomes for patients compared with other advanced economies. It ranks second from bottom for healthy life expectancy and preventable and treatable mortality.
We need to make sure that healthcare funding is sustainable while maintaining the principle of universality to ensure that those on modest incomes still get free healthcare.
People with middle and high incomes should start paying for certain services. For example, there should be a £20 fee for a GP appointment, as well as a charge for certain elective procedures.
Free prescriptions and sight and hearing tests for the over-60s should also be abolished. However, all these services should remain free for people on low incomes.
• Read more money advice and tips on investing from our experts
Of course, we should not adopt the failed US system, which is not only far more expensive but also leaves many people uninsured and with worse outcomes. Instead, the UK should follow the example of most other European countries and shift to a mixed-funding model.
In these countries citizens are required to have health insurance, which is supplemented by co-payments and charges, meaning that wealthier patients who can pay do. Their systems are sustainable, produce better patient outcomes, and ensure that those on low incomes and vulnerable people have access to healthcare.
Such a shift would be radical, but it is necessary. It has the potential to lower costs, reduce the burden on taxpayers, and improve patient outcomes. It is the only way that we can ensure that the NHS is there for us today and in the future.
The British Social Attitudes survey, which has been conducted every year since 1983, makes grim reading for the NHS, but reports of its death are greatly exaggerated.
While only 21 per cent of respondents are satisfied with the way the NHS is run, more than 90 per cent support its central tenet: free at the point of need. People are committed to the principle that everybody, no matter how rich or poor, should have access to treatment, even when dissatisfied with the performance of the NHS.
We want our healthcare system to mirror us as a nation united: the last remnants of Blitz spirit and post-war consensus. I can think of little that would sow the seeds of discontent across our fractured nation faster than implementing a policy that can only bring about a two-tier healthcare system.
Allowing hospitals to charge higher earners is tailor-made for perverse incentives that distort inequalities. Given the present financial crisis, what chief executive would not prioritise the patient who could provide income, even if the clinical need between two patients was equal?
And what would it do to trust in the NHS when patients don't know whether their delayed operation is due to clinical need or the size of their wallet?
• Hospital funding will be tied to patient ratings in NHS overhaul
Hospitals in affluent areas already have recruitment advantages. Revenue generation enables investment in staff, equipment, and facilities, leaving the rest to slip even further behind. This ultimately widens the equality gap for those in disadvantaged communities who are most reliant on free healthcare.
Finally, could this be successful? Do we want our cash-strapped NHS to waste resources on hiring marketeers to compete for private demand rather than developing the health prevention messages critical to reducing future costs?
I say this as a great supporter of the NHS. No healthcare system is perfect, but few have principles such as 'free at the point of use' held in such high esteem by its users. It is a principle that many other nations look at with envy.
So, no, the state should not overreach itself by getting richer to pay to use the NHS. Ill-conceived plans like this would sound the death knell for our greatest public institution.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

OpenAI stops ChatGPT from telling people to break up with partners
OpenAI stops ChatGPT from telling people to break up with partners

The Guardian

timean hour ago

  • The Guardian

OpenAI stops ChatGPT from telling people to break up with partners

ChatGPT will not tell people to break up with their partner and will encourage users to take breaks from long chatbot sessions, under new changes to the artificial intelligence tool. OpenAI, ChatGPT's developer, said the chatbot would stop giving definitive answers to personal challenges and would instead help people to mull over problems such as potential breakups. 'When you ask something like: 'Should I break up with my boyfriend?' ChatGPT shouldn't give you an answer. It should help you think it through – asking questions, weighing pros and cons,' said OpenAI. The US company said new ChatGPT behaviour for dealing with 'high-stakes personal decisions' would be rolled out soon. OpenAI admitted this year that an update to ChatGPT had made the groundbreaking chatbot too agreeable and altered its tone. In one reported interaction before the change, ChatGPT congratulated a user for 'standing up for yourself' when they claimed they had stopped taking their medication and left their family – who the user had thought were responsible for radio signals emanating from the walls. In the blog post, OpenAI admitted that there had been instances where its advanced 4o model had not recognised signs of delusion or emotional dependency – amid concerns that chatbots are worsening people's mental health crises. The company said it was developing tools to detect signs of mental or emotional distress so ChatGPT can direct people to 'evidence-based' resources for help. A recent study by NHS doctors in the UK warned that AI programs could amplify delusional or grandiose content in users vulnerable to psychosis. The study, which has not been peer reviewed, said the programs' behaviour could be because the models were designed to 'maximise engagement and affirmation'. The study added that even if some individuals benefited from AI interactions, there was a concern the tools could 'blur reality boundaries and disrupt self-regulation'. OpenAI added that from this week it would send 'gentle reminders' to take a screen break to users engaging in long chatbot sessions, similar to screen-time features deployed by social media companies. OpenAI also said it had convened an advisory group of experts in mental health, youth development and human-computer-interaction to guide its approach. The company has worked with more than 90 doctors, including psychiatrists and paediatricians, to build frameworks for evaluating 'complex, multi-turn' chatbot conversations. 'We hold ourselves to one test: if someone we love turned to ChatGPT for support, would we feel reassured? Getting to an unequivocal 'yes' is our work,' said the blog post. The ChatGPT alterations were announced amid speculation that a more powerful version of the chatbot is imminent. On Sunday Sam Altman, OpenAI's chief executive, shared a screenshot of what appeared to be the company's latest AI model, GPT-5.

Treatment for advanced womb cancer ‘major step forward'
Treatment for advanced womb cancer ‘major step forward'

South Wales Argus

timean hour ago

  • South Wales Argus

Treatment for advanced womb cancer ‘major step forward'

Just 15% of women live for five years if they have been diagnosed with advanced (stage four) endometrial cancer – a cancer which usually starts in the lining of the womb. The treatment, pembrolizumab, can slow down cancer growth and improve survival odds, health officials said. The National Institute for Health and Care Excellence (Nice) estimates that around 2,100 women will benefit from the treatment each year. It said that its approval of the treatment for the NHS in England marks a 'major step forward' in treatment for women with this type of cancer. The treatment, also known as Keytruda and made by Merck Sharp and Dohme, is an immunotherapy drug and is delivered in a drip alongside chemotherapy drugs carboplatin and paclitaxel and can be given for up to two years. Nice said that clinical trials show the combination of treatments reduced the risk of death by 26% compared to chemotherapy alone. The treatments can also slow down cancer progression, it added. 'For people with advanced endometrial cancer, this innovative combination offers a powerful new treatment option,' said Helen Knight, director of medicines evaluation at Nice. 'It marks a major step forward, and we're pleased to recommend it as part of our commitment to getting the best care to people, fast, while ensuring value for the taxpayer.' Around 9,700 women are diagnosed with endometrial cancer each year, Nice said, making it the most common gynaecological cancer in the UK. Helen Hyndman, lead nurse at the charity Eve Appeal's information service Ask Eve, said: 'Primary advanced or recurrent womb (endometrial) cancer has a huge impact on the quality of life for those diagnosed. 'It is great news that this new treatment has been approved. 'It will offer hope, a better quality of life and improve outcomes for those affected.' Professor Peter Johnson, NHS England's national clinical director for cancer, said: 'Getting this treatment to many more NHS patients as quickly as possible will help thousands of women live longer, allowing them to spend more time with loved ones and give them a better quality of life. 'Thanks to the NHS's Cancer Drugs Fund, it is now being fast-tracked into routine use, with treatment available to more patients from today.'

Women can now claim almost £1,000 for 'gifting' their eggs and demand has never been greater. But for many the procedure is painful, has been linked to serious health conditions and leaves a lifetime of troubling questions
Women can now claim almost £1,000 for 'gifting' their eggs and demand has never been greater. But for many the procedure is painful, has been linked to serious health conditions and leaves a lifetime of troubling questions

Daily Mail​

timean hour ago

  • Daily Mail​

Women can now claim almost £1,000 for 'gifting' their eggs and demand has never been greater. But for many the procedure is painful, has been linked to serious health conditions and leaves a lifetime of troubling questions

Leena Khan was a 21-year-old university student when she saw the Facebook advert seeking egg donors: giving would be a selfless act, the fertility clinic said. 'I've always gone out of my way to help people,' says Leena – and with £750 expenses offered, the money would help fund her studies. As far as ideas go, she says, 'it didn't seem crazy'. Within months of donating, however, Leena started suffering painful, heavy periods.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store